Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

4x13 Webinar

13 min on IL-4/13 Inhibition for EoE (Eosinophilic Esophagitis)

Diabetes och Ramadan

2026 infaller Ramadan mellan 17 februari och 19 mars. Vi har tagit fram material för att hjälpa dig att stötta din patient med diabetes som vill fasta under Ramadan.

When to Start People with Diabetes on Insulin

Key indicators and timing for insulin initiation in Type 2 diabetes care pathways

Sanofi's Commitment to Diabetes

Supporting you with reliable and sustainable insulin supply

How to start and switch insulin: a HCP guide

A practical guide for initiating or switching patients to a new insulin

GLOBAL & INDIAN BURDEN OF DIABETES WITH ITS PATHOPHYSIOLOGY & PROGRESSION OF THE DISEASE

COMPLICATIONS OF DIABETES IF NOT CONTROLLED

GLOBAL & INDIAN BURDEN OF DIABETES WITH ITS PATHOPHYSIOLOGY & PROGRESSION OF THE DISEASE

Manage a Patient with Hypertension, Diabetes, and
Chronic Kidney Disease

Manage a Patient with Hypertension, Diabetes, and Chronic Kidney Disease.